GRX-51

N/A

Report date: 2023/05/22 10:15:49
NME

Base Information

Drug NameGRX-51
Drug Alias NameGRX-51
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionImmunostimulantsWnt signalling pathway inhibitorsGlypican-3 modulators
TargetsGlypican-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGuardian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGuardian Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A